These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16762915)

  • 1. The ferrous-dioxygen intermediate in human cytochrome P450 3A4. Substrate dependence of formation and decay kinetics.
    Denisov IG; Grinkova YV; Baas BJ; Sligar SG
    J Biol Chem; 2006 Aug; 281(33):23313-8. PubMed ID: 16762915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The one-electron autoxidation of human cytochrome P450 3A4.
    Denisov IG; Grinkova YV; McLean MA; Sligar SG
    J Biol Chem; 2007 Sep; 282(37):26865-26873. PubMed ID: 17650504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
    Perret A; Pompon D
    Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ferrous-oxy complex of human aromatase.
    Grinkova YV; Denisov IG; Waterman MR; Arase M; Kagawa N; Sligar SG
    Biochem Biophys Res Commun; 2008 Jul; 372(2):379-82. PubMed ID: 18482580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperativity in cytochrome P450 3A4: linkages in substrate binding, spin state, uncoupling, and product formation.
    Denisov IG; Baas BJ; Grinkova YV; Sligar SG
    J Biol Chem; 2007 Mar; 282(10):7066-76. PubMed ID: 17213193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of substrate on the spectral properties of oxyferrous wild-type and T252A cytochrome P450-CAM.
    Sono M; Perera R; Jin S; Makris TM; Sligar SG; Bryson TA; Dawson JH
    Arch Biochem Biophys; 2005 Apr; 436(1):40-9. PubMed ID: 15752707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidase uncoupling in heme monooxygenases: human cytochrome P450 CYP3A4 in Nanodiscs.
    Grinkova YV; Denisov IG; McLean MA; Sligar SG
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1223-7. PubMed ID: 23266608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
    Hosea NA; Miller GP; Guengerich FP
    Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment.
    Baas BJ; Denisov IG; Sligar SG
    Arch Biochem Biophys; 2004 Oct; 430(2):218-28. PubMed ID: 15369821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-embedded substrate recognition by cytochrome P450 3A4.
    Hackett JC
    J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane properties induced by anionic phospholipids and phosphatidylethanolamine are critical for the membrane binding and catalytic activity of human cytochrome P450 3A4.
    Kim KH; Ahn T; Yun CH
    Biochemistry; 2003 Dec; 42(51):15377-87. PubMed ID: 14690448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of active site water molecules and substrate hydroxyl groups in oxygen activation by cytochrome P450 158A2: a new mechanism of proton transfer.
    Zhao B; Guengerich FP; Voehler M; Waterman MR
    J Biol Chem; 2005 Dec; 280(51):42188-97. PubMed ID: 16239228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding to cytochrome P450 3A4 in phospholipid bilayer nanodiscs: the effect of model membranes.
    Nath A; Grinkova YV; Sligar SG; Atkins WM
    J Biol Chem; 2007 Sep; 282(39):28309-28320. PubMed ID: 17573349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
    Isin EM; Guengerich FP
    J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome b
    Duggal R; Denisov IG; Sligar SG
    FEBS Lett; 2018 Jul; 592(13):2282-2288. PubMed ID: 29888793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational heterogeneity of cytochrome P450 3A4 revealed by high pressure spectroscopy.
    Davydov DR; Halpert JR; Renaud JP; Hui Bon Hoa G
    Biochem Biophys Res Commun; 2003 Dec; 312(1):121-30. PubMed ID: 14630029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
    Yamazaki H; Ueng YF; Shimada T; Guengerich FP
    Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
    Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
    Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.